+ All Categories
Home > Documents > Respiratory Disorders

Respiratory Disorders

Date post: 13-May-2017
Category:
Upload: suleiman-abdallah
View: 214 times
Download: 2 times
Share this document with a friend
19
1 RESPIRATORY DISORDERS Respiratory Tract Drugs To treat acute & minor conditions 1. Nasal congestion 2. Cough 3. Seasonal allergies To treat chronic & serious conditions 1. Bronchial Asthma 2. Chronic bronchitis 3. Cystic fibrosis 4. Emphysema
Transcript
Page 1: Respiratory Disorders

1

RESPIRATORY DISORDERS

Respiratory Tract Drugs

To treat acute & minor

conditions

1. Nasal congestion

2. Cough

3. Seasonal allergies

To treat chronic &

serious conditions

1. Bronchial Asthma

2. Chronic bronchitis

3. Cystic fibrosis

4. Emphysema

Page 2: Respiratory Disorders

2

Drugs used to treat respiratory tract irritation &

control secretion

These drugs are used to treat symptoms of cough &

irritation that result from:

– Common cold

– Seasonal allergies

– Upper respiratory tract infections.

This group includes:

1. Antitussives

2. Decongestant

3. Antihistamines

4. Mucolytics & Expectorants

1-Antitussives

• The drugs used to suppress cough associated with common cold &

minor throat irritation.

• They are usually prescribed only for short term use in relieving

symptomatic coughing.

1. Codeine

2. Hydrocodone

3. Diphenhydramine

Common side effects are: Sedation, Dizziness, GIT upset

Page 3: Respiratory Disorders

3

• Congestion & mucosal discharge (runny nose) are features of many

respiratory conditions like:

1. Allergies

2. Common cold

3. Respiratory Tract Infections

• Most of the used drugs are alpha-1 agonists to stimulate the alpha-1

receptors in the blood vessels of the nasal mucosa.

• It cause vasoconstriction & effectively drying up the mucosal

vasculature & decreasing local congestion in the nasal passages.

• Can be given systemically or locally.

Common side effects are: Headache, Dizziness, Nervousness, Nausea

and CVS problems

2-Decongestants

3-Anti-histamines

• Histamine is an endogenous chemical that regulate many

physiologic functions:

• Gastric secretion

• CNS modulation

• Hypersensitivity (allergic) reactions.

Page 4: Respiratory Disorders

4

Type of

receptor Location Function

H1 • Smooth muscle

• Endothelium

• CNS

• Vasodilation

• Bronchoconstriction

• Redness, pain and itching

• Motion sickness

• Sleep regulation.

H2 • Parietal cells in

stomach

• Stimulate gastric acid secretion

H3 • CNS •Decrease neurotransmitter release:

histamine, acetylcholine,

norepinephrine, serotonin

H4 • Basophils

• Bone marrow

• Plays a role in chemotaxis.

3-Anti-histamines

Histamine receptors

• They specifically block H1-receptors.

• These drugs are used in rhinitis, sinusitis & conjunctivitis to

decrease:

o Nasal congestion

o Mucosal irritation

o Discharge

o Cough

o Sneezing

3-Anti-histamines

Page 5: Respiratory Disorders

5

Sedating antihistamines

(e.g. diphenhydramine)

Selected adverse effects:

Dry mouth

Hypotension

CNS depression

Antimuscarinic

3-Anti-histamines

Less sedating antihistamines

(e.g. Loratadine)

Little access to brainNo antimuscarinic actions

Selected adverse effects Dry mouth, drowsiness, fatigue, headache

3-Anti-histamines

Page 6: Respiratory Disorders

6

4-Mucolytics & Expectorants

Mucolytics are drugs that decrease viscosity of respiratory

secretions.

Expectorants are drugs which facilitate production &

ejection of mucous.

• These drugs are used to prevent the accumulation of

thick & viscous secretions that may block the respiratory

passages & lead to pulmonary problems.

Drugs used to treat chronic

&

serious conditions

Page 7: Respiratory Disorders

7

• Airway obstruction is a major problem in respiratory

disorders such as

o Bronchial asthma

o Cystic fibrosis

o Chronic bronchitis

o Emphysema

• The goal of drug therapy of these conditions is to prevent

or reverse the bronchial constriction & obstruction of the

airways by the use of

o Bronchodilators

o Anti-inflammatory agents.

COPD

Bronchodilators

• This group of drugs used to treat bronchospasm. It includes:

1. Beta adrenergic agonists

2. Theophylline

3. Anticholinergics

4. Sodium cromoglycate

Page 8: Respiratory Disorders

8

1- Beta Adrenergic Agonist Drugs

• They bind to Beta-2 receptors, stimulating them & result in

relaxation of the respiratory smooth muscles and produce

bronchodilation.

• Also can be used to prevent bronchospasm (Prophylactic) .

Adverse Effects:

o Bronchial irritation (inhalers)

o Cardiac irregularities (non selectivity)

o Stimulation of CNS adrenergic receptors.

2- Theophylline

It has the following effects:

o Bronchodilation

o Increase mucociliary transport

o Decrease pulmonary artery pressure

o Increase respiratory muscles strength

o Limit the release of inflammatory mediators

Adverse Effects:

o Nausea, vomiting, confusion, irritability, cardiac

arrhythmias, seizure.

Page 9: Respiratory Disorders

9

3- Anticholinergic Drugs

• Atropine & Ipratropium

• Anticholinergic drugs can inhibit bronchoconstriction in

cases of bronchial asthma & COPD.

Side effects

• Dry mouth

• Tachycardia

• Constipation

• Urine retention

• Blurring of vision

4-Sodium Cromoglycate

• This drug is commonly used to prevent bronchospasm (prophylaxis)

initiated by exercise.

• Stabilizes the pulmonary mast cells & inhibits the release of

inflammatory mediators (histamine & leukotrienes).

• It can be given by:

o Inhalation

o Nebulizer

o Nasal spray

Side effects:

• Irritation to the upper respiratory passages when given by inhalation.

Page 10: Respiratory Disorders

10

Anti-inflammatory Drugs

• Inflammation is an important factor for the

bronchospasm in case of bronchial asthma & COPD.

• Corticosteroids have very potent anti-inflammatory

effects so they can control inflammation mediated

bronchoconstriction.

• NSAIDs should not be used (Why?)

Bronchial Asthma

Page 11: Respiratory Disorders

11

• Asthma is a chronic inflammatory disorder of the

airway caused mostly by an immunologic reaction

• Is a disease of the respiratory tract in which there is

widespread airways obstruction.

• Three factors contribute to the narrowing of airways.

1. Mucosal cells swelling/inflammation

(responds well to steroids)

2. Mucous formation

3. Bronchial smooth muscle contraction

(responds to Beta-2 agonists)

BronchialAsthma

Clinical Features:

1.Intermittent wheeze

2.Dyspnoae

3.Cough

Precipitating Factors:

o Emotion

o Exercise

o Infection

o Allergens

o Drugs

o Cold air

BronchialAsthma

Page 12: Respiratory Disorders

12

Management of Bronchial Asthma

• Bronchodilators

• Theophylline

• Corticosteroids

Non-pharmacologic Management

1. Identification of the initiating factors

2. Aerobic exercise (swimming) is excellent to improve

cardiorespiratory function in patient with asthma without

causing bronchospasm.

BronchialAsthma

BronchialAsthma

Page 13: Respiratory Disorders

13

Chronic Obstructive Pulmonary Disease

(COPD)

Chronic Obstructive Pulmonary Disease

(COPD)

• Is persistent obstruction of the airways.

Page 14: Respiratory Disorders

14

Chronic Bronchitis

• Long-standing inflammation of the bronchial tree

• Characterized by production of sputum on most days

for 3 months of 2 successive years.

• May cause obstruction and narrowing of the airway

lumen with excess mucous.

COPD

Emphysema

• A pathological condition in which there is dilatation of

the air spaces by destruction of the alveolar walls.

• Obstruction results from the decrease of the lungs’

elasticity, which normally holds the airways open in

expiration.

COPD

Page 15: Respiratory Disorders

15

1. Smoking

2. Alpha-1 anti-trypsin deficiency

COPD

Smoking

• Cigarette smoking is the most important cause of COPD, although only about 15% of smokers developthe disease.

• Lung function improves only a little if people stop

smoking.

• With aging, susceptible cigarette smokers lose

lung function more rapidly than nonsmokers.

Page 16: Respiratory Disorders

16

Alpha1-Antitrypsin (A1AT)

• A1AT is an enzyme produced by the liver which

inhibits the action of other enzymes called proteases.

• Proteases break down proteins as part of normal

tissue repair.

• A1AT protects the lungs from the damaging effects of

proteases.

• Genetic deficiency of A1AT or due to smoking causes

Emphysema.

1. Cough

2. Excessive Sputum

3. Dyspnoea

4. Wheezing

5. Hyperinflation

6. Cyanosis

7. Loss of weight

Features of COPD

Page 17: Respiratory Disorders

17

The aim of treatment is to maintain the airway open & prevent

airflow restriction.

1. Bronchodilators (β-2 agonist , anticholinergic,theophylline)

2. Corticosteroids

3. Mucolytics & Expectorants

4. Chest physiotherapy

Treatment of COPD

Cystic Fibrosis

Page 18: Respiratory Disorders

18

Cystic Fibrosis

• It is a hereditary disease characterized by abnormal transport of

chloride and sodium across an epithelium, leading to thick,

viscous secretions

• Mucous plugging of the bronchioles may result in:

1. Pneumonia

2. Bronchitis

3. Pulmonary fibrosis

The aim of treatment is to maintain the airway patent as much

as possible.

1. Bronchodilators

2. Mucolytics & Expectorants

3. Corticosteroids

4. Antibiotics to treat infections

Treatment of Cystic Fibrosis

Page 19: Respiratory Disorders

19

Thank you


Recommended